Showing results (1-10 of 145) with videos related to
Sort By:
Pageof 15
Current Opinion in Investigational Drugs (London, England : 2000)|June 11, 2002
Current treatment options in neuropathic painKathleen Hempenstall, Andrew S C RicePlos Medicine|July 15, 2005
Analgesic therapy in postherpetic neuralgia: a quantitative systematic reviewKathleen Hempenstall, Turo J Nurmikko, Robert W Johnson, et al.Anesthesia and Analgesia|November 16, 2022
Improving Preclinical Development of Novel Interventions to Treat Pain: Insanity Is Doing the Same Thing Over and Over and Expecting Different ResultsJames C Eisenach, Andrew S C RiceAnnual Review of Medicine|January 18, 2006
New treatments for neuropathic painAndrew S C Rice, Raymond G HillPain|June 1, 1994
Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP-5) prevents hyper-reflexia in a model of persistent visceral painAndrew S C Rice, Stephen B McMahonAnesthesiology|November 26, 2003
A novel neuroimmune mechanism in cannabinoid-mediated attenuation of nerve growth factor-induced hyperalgesiaW Paul Farquhar-Smith, Andrew S C RicePain Reports|December 26, 2019
VGF: a biomarker and potential target for the treatment of neuropathic pain?Nadia Soliman, Kenji Okuse, Andrew S C RiceAnesthesiology|September 18, 2025
Topical Analgesics: Pharmacology and Clinical ApplicationsMarco Sisignano, Andrew S C Rice, Gerd GeisslingerPain|January 20, 2016
Selective small molecule angiotensin II type 2 receptor antagonists for neuropathic pain: preclinical and clinical studiesMaree T Smith, Praveen Anand, Andrew S C RiceAnnals of the New York Academy of Sciences|January 4, 2012
Novel, nonreflex tests detect analgesic action in rodents at clinically relevant concentrationsNick Andrews, Sinead Harper, Yasmin Issop, et al.Pageof 15